Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01592370
Title An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | GRC | FRA | BEL

Facility Status City State Zip Country Details
Local Institution - 0035 Clovis California 93611 United States Details
Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles California 90095 United States Details
Local Institution - 0012 Los Angeles California 90095 United States Details
Local Institution - 0017 Aurora Colorado 80045 United States Details
Local Institution - 013 New Haven Connecticut 06520 United States Details
Local Institution - 0023 Orlando Florida 32804 United States Details
Local Institution - 0037 Skokie Illinois 60077 United States Details
Local Institution - 0019 Indianapolis Indiana 46202 United States Details
Local Institution - 0018 Westwood Kansas 66205 United States Details
Local Institution - 0003 Baltimore Maryland 21231 United States Details
The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Local Institution - 0009 Boston Massachusetts 02215 United States Details
Local Institution - 0015 Boston Massachusetts 02215 United States Details
Local Institution - 0011 Ann Arbor Michigan 48109 United States Details
University Of Michigan Health System Ann Arbor Michigan 48109 United States Details
Local Institution - 0002 Rochester Minnesota 55905 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Local Institution - 0033 Omaha Nebraska 68130 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Local Institution - 0014 Hackensack New Jersey 07601 United States Details
Local Institution - 0001 New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Local Institution - 0028 Columbus Ohio 43210 United States Details
Local Institution - 0006 Portland Oregon 97239 United States Details
OHSU Center for Hematologic Malignancies Portland Oregon 97239 United States Details
Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Local Institution - 0007 Philadelphia Pennsylvania 19104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Local Institution - 0004 Philadelphia Pennsylvania 19111 United States Details
Huntsman Cancer Institute At The Univ. Of Utah Salt Lake City Utah 84112 United States Details
Local Institution - 0005 Salt Lake City Utah 84112 United States Details
Local Institution - 0045 Gent 9000 Belgium Details
Local Institution - 0047 Sint-Niklaas 9100 Belgium Details
Local Institution Yvoir B-5530 Belgium Details
Local Institution - 0043 Poitiers Vienne 86021 France Details
Local Institution - 0044 Nantes Cedex 1 44000 France Details
Local Institution - 0039 Athens 11528 Greece Details
Local Institution Bologna 40138 Italy Details
Local Institution Chorzow 41-500 Poland Details
Local Institution - 0040 Poznan 61-848 Poland Details
Local Institution - 0049 Warszawa 02-776 Poland Details
Local Institution - 0042 Wroclaw 50-367 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field